About Cell Therapy
There are 831 companies in the Cell Therapy sector across the world, with 607 funded companies having collectively raised $34.2B in venture capital money and private equity. Overall 353 of these are Series A+ funded and the sector has seen the creation of 3 Unicorns.
Cell Therapy sector has seen 71 acquisitions and 121 IPOs. This represents almost 23.1% of all such companies - which is higher than the 4.9% exit rate of tech companies in general.
This sector includes companies developing cellular therapies to treat diseases in humans.
Companies included in Cell Therapy sector
Companies developing stem cell and somatic cell based therapies for the treatment of various diseases.Companies excluded in Cell Therapy sector
Companies developing drugs or therapeutics for animal healthcare Companies that provide digital solutions like an app, software, web portals for the management/treatment of diseases. Companies developing non cellular therapies for the treatment of diseases.Market Map of Cell Therapy
The market map of Cell Therapy gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution.
Reports related to Cell Therapy
Here is a report related to Cell Therapy sector:
View all reports related to Cell Therapy. Sign up today!Top Companies in Cell Therapy
There are more than 831 companies in Cell Therapy. Sana Biotechnology is the top Cell Therapy company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top Cell Therapy companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of genetically engineered cell therapies for multiple disorders | Seattle (United States) | 2018 | Public | $821M | |
Global biopharmaceutical company discovering, developing, and delivering innovative medicines | Seattle (United States) | 2013 | Acquired | $317M | |
Developer of regenerative and gene therapeutics for heart failure | San Francisco (United States) | 2016 | Public | $248M | |
Developer of cell and gene therapies for cancer treatment | Mumbai (India) | 2018 | Series B | $15.9M | |
Developer of cancer immunotherapy products using genetic engineering | Los Angeles (United States) | 2009 | Acquired | $97.7M |
Companies founded year-on-year in the Cell Therapy sector
60 Cell Therapy startups were founded in 2020 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | - |
2024 | 7 |
2023 | 13 |
2022 | 30 |
2021 | 54 |
2020 | 60 |
2019 | 42 |
2018 | 47 |
2017 | 54 |
Companies founded across countries in the Cell Therapy sector
United States has 415 Cell Therapy startups, the most by any country, followed by China which has 60 startups and South Korea which has 49.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 415 |
China | 60 |
South Korea | 49 |
United Kingdom | 35 |
Israel | 30 |
Japan | 28 |
India | 25 |
Germany | 21 |
Canada | 18 |
France | 17 |
Stage-wise distribution of the Cell Therapy sector
Out of the total 831 Cell Therapy companies, 607 have secured funding. Among them, 353 have reached Series A or higher, and 265 to Series B or beyond.
Founded - 831
Funded - 607
Series A+ - 353
Series B+ - 265
Series C+ - 218
Company Stage | No. of companies |
|---|---|
Founded | 831 |
Funded | 607 |
Series A+ | 353 |
Series B+ | 265 |
Series C+ | 218 |
Want to know more about Cell Therapy ? Signup and explore Tracxn for free
- 830+ Total Companies
- $34.2B+ Total Funding
- 605+ Funded Companies
- 120+ IPOs
- 70+ Acquisitions
- 5+ Reports
Funding Trends in the Cell Therapy sector
Total funding year-on-year in the Cell Therapy sector
The Cell Therapy sector saw a total funding of more than $26.1B in the last 10 years. The most amount of funding was in 2017 at more than $5.25B. There has been a total funding of $395M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $395M |
2025 | $1.75B |
2024 | $2.44B |
2023 | $1.96B |
2022 | $2.25B |
2021 | $3.32B |
2020 | $3.57B |
2019 | $2.42B |
2018 | $2.77B |
2017 | $5.25B |
Total funding across countries in the Cell Therapy sector
In the last 10 years, Cell Therapy startups in United States have recieved the highest funding among all countries - $19.9B. China follows with $1.65B and United Kingdom with $883M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $19.9B |
China | $1.65B |
United Kingdom | $883M |
Australia | $599M |
France | $516M |
Israel | $337M |
Japan | $161M |
Canada | $143M |
South Korea | $116M |
India | $52.3M |
Total funding amount raised by stage in the Cell Therapy sector
Over the last 10 years, the Cell Therapy sector have seen $522M into Seed Stage funding rounds, $10.4B into Early Stage funding rounds and $5.87B go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Early Stage | $10.4B |
Late Stage | $5.87B |
Post IPO | $5.17B |
Debt | $3.42B |
Seed Stage | $522M |
Grant | $490M |
Other-Equity | $30M |
Recent Funding Rounds in Cell Therapy
In the year 2026, till March 2026, Cell Therapy companies have raised $378M in equity funding across 7 rounds.
In the same period last year (i.e. till March 2025), Cell Therapy companies had raised $440M across 11 rounds.
So, 2026 has seen a 14.18% drop in funding in Cell Therapy companies as compared to 2025.
Here are some recent, important funding rounds in Cell Therapy:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Seed | 8228 | Mar 25, 2026 | ||
Series B | 2973 | Mar 24, 2026 | ||
Seed | 7040 | Mar 09, 2026 | - | |
Series B | 9015 | Jan 27, 2026 | ||
Series B | 9862 | Jan 12, 2026 |
Top Investors in Cell Therapy
HHS is the top investor in Cell Therapy companies based on number of companies invested.
Here are some top investors in Cell Therapy:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Boston (United States) | ||
Chicago (United States) | ||
Falls Church (United States) |
M&A activity in Cell Therapy
In the year 2026, till February 2026, 1 acquisition happened in Cell Therapy sector. Last year, in 2025, a total of 6 acquisitions happened in Cell Therapy sector.
Here are some recent, important acquisitions in Cell Therapy:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Feb 23, 2026 | ||
Business Acquisition | Aug 04, 2025 | ||
Business Acquisition | Jul 08, 2025 | ||
Business Acquisition | Jul 01, 2025 | ||
Business Acquisition | May 28, 2025 |
Acquisition trends in Cell Therapy
Here are the acquisition trends in Cell Therapy:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 1 |
2025 | 6 |
2024 | 4 |
2023 | 3 |
2022 | 3 |
2021 | 7 |
2020 | 7 |
2019 | 9 |
2018 | 9 |
2017 | 7 |
IPOs in Cell Therapy
In the year 2026, till February 2026, 1 IPO happened in Cell Therapy sector.
Here are some recent, important IPOs in Cell Therapy:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Feb 24, 2026 | Tokyo Stock Exchange (TYO) | |
Dec 31, 2025 | London Stock Exchange (LSE) | |
Nov 12, 2024 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jul 19, 2024 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Mar 11, 2024 | Taipei Stock Exchange (TT) |
Colleges which produce the most Cell Therapy companies
Companies founded by alumni from top colleges in the Cell Therapy sector
Most number of Cell Therapy startups have been founded by alumni from Harvard University, Massachusetts Institute of Technology and Stanford University.
College | No. of companies |
|---|---|
Harvard University | 25 |
Massachusetts Institute of Technology | 15 |
Stanford University | 14 |
University of Oxford | 11 |
University of Pennsylvania | 9 |
University of California (Berkeley) | 8 |
Tel Aviv University | 6 |
University of Cambridge | 6 |
Yale University | 6 |
Columbia University | 5 |
Total funding in companies founded by alumni from top colleges in the the Cell Therapy sector
In the last 10 years, University of California (Berkeley) graduates' Cell Therapy companies have raised the most funding among top colleges. Harvard University alumni are second, and Massachusetts Institute of Technology alumni are third.
College | Total Funding |
|---|---|
University of California (Berkeley) | $3.63B |
Harvard University | $2.36B |
Massachusetts Institute of Technology | $1.94B |
Stanford University | $1.93B |
Yale University | $1.67B |
McGill University | $907M |
Duke University | $890M |
Cornell University | $725M |
University of Pennsylvania | $657M |
University of Chicago | $570M |
Top News in Cell Therapy
•
•
•
Capricor Therapeutics Announces HOPE-3 Data at MDA ConferenceGlobeNewswire•Mar 12, 2026•Capricor Therapeutics
•
EMA Grants PRIME Designation to TolerogenixX’s MIC-Lx TherapyGlobeNewswire•Mar 11, 2026•Tolerogenixx
•
•
XellSmart Receives FDA & China NMPA Clearance for MSA-P Cell TherapyPR Newswire•Mar 02, 2026•Shize Bio
•
•
Organogenesis Holdings GAAP EPS of $0.24 beats by $0.03, revenue of $225.1M beats by $52.42MSeeking Alpha•Feb 26, 2026•Organogenesis
•
TScan Receives FDA Clearance for Heme Candidates TSC-102-A01 and TSC-102-A03GlobeNewswire•Feb 26, 2026•TScan Therapeutics
•
